HomeCTOR • NASDAQ
add
Citius Oncology Inc
Previous close
$1.14
Day range
$1.10 - $1.13
Year range
$0.55 - $6.19
Market cap
98.85M USD
Avg Volume
181.13K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 3.94M | — |
Operating expense | 8.41M | 31.47% |
Net income | -5.53M | 16.90% |
Net profit margin | -140.31 | — |
Earnings per share | — | — |
EBITDA | -4.68M | — |
Effective tax rate | -5.01% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.30M | 6,513,695.54% |
Total assets | 109.97M | 21.54% |
Total liabilities | 51.56M | 4.81% |
Total equity | 58.41M | — |
Shares outstanding | 88.28M | — |
Price to book | 1.65 | — |
Return on assets | -12.45% | — |
Return on capital | -23.68% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -5.53M | 16.90% |
Cash from operations | -7.35M | — |
Cash from investing | -4.40M | — |
Cash from financing | 15.13M | — |
Net change in cash | 3.37M | — |
Free cash flow | -14.20M | -691.98% |
About
Founded
2021
Headquarters
Website
